 Oragenics, Inc. NYSE American: OGEN, a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, today announced that Alan Joslyn, Ph.D., president and CEO of Oragenics, Inc. will be a featured presenter at the LD Micro Main Event on Tuesday, December 10, 2019 at 1:00 PM Pacific Time at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. For those interested in attending or for registered attendees who wish to request meetings, please contact David Scher at or visit for more information. We are focused on becoming a leader in novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. 